Acronym
miRNA-Chemoresistance
Code
F2016/IOF-CONTT/002
Duration
15 April 2016 → 30 September 2018
Funding
Regional and community funding: Industrial Research Fund
Promotor
Research disciplines
-
Medical and health sciences
- Morphological sciences
- Oncology
- Morphological sciences
- Oncology
- Morphological sciences
- Oncology
Keywords
chmeotherapeutic drugs
Project description
In vivo POC study for an anti-miRNA combination adjuvant therapy towards avoiding chemotherapy drug resistance